Baskett Forest, a ten percent owner of Korro Bio, Inc. (NASDAQ:KRRO), has purchased 207,100 shares of common stock at a price of $11.11, in a transaction totaling $2,300,881. The ...

Financing led by new investor Venrock Healthcare Capital Partners, with participation from new and existing investorsProceeds support the ...

Korro Bio Inc. KRRO shares are up on Friday as the company reported its fourth-quarter and full-year financial results, ...

) has been revised to $17.34 / share. This is a decrease of 62.22% from the prior estimate of $45.90 dated January 11, 2026. The price target is an average of many targets provided by analysts. The ...

The average one-year price target for Korro Bio (NasdaqCM:KRRO) has been revised to $19.53 / share. This is an increase of 12.61% from the prior estimate of $17.34 dated February 1, 2026. The price ...

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and mining exploration companies often lose money for years before finding success with ...

Everyone. Good morning. Thank you all for joining us today. My name is Henry Jiang. I'm with the banking team here at JPMorgan, and it's my pleasure to be introducing Korro Bio today. Joining us on ...

Korro Bio started trading on NASDAQ after acquiring Frequency Therapeutics in a reverse merger deal. Korro's platform enables a broad pursuit of indications with an initial focus on six potential ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

Mathers, a ten percent owner of Korro Bio, Inc. (NASDAQ:KRRO), recently purchased 207,100 shares of common stock at a price ...